-36.4%
IONQ vs MRNA
+755.5%
-791.9%
-63.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.4% | -3.4% | -3.0% | -6.2% |
| 7D | -11.5% | -12.1% | +0.7% | -10.8% |
| 30D | -8.1% | -1.3% | -6.8% | -7.9% |
| 3M | -35.8% | +250.9% | -286.7% | -39.7% |
| 6M | -47.7% | +343.0% | -390.8% | -55.5% |
| YTD | -35.6% | +657.4% | -693.1% | -57.2% |
| 1Y | -36.4% | +794.9% | -831.3% | -61.9% |
| All | -36.4% | +755.5% | -791.9% | -61.9% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling